Literature DB >> 16420362

Anti-phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M-related protein.

Harry S Courtney1, David L Hasty, James B Dale.   

Abstract

A key attribute of invasive Streptococcus pyogenes is their ability to resist phagocytosis and multiply in human blood. M-related protein (Mrp) is a major anti-phagocytic factor but the mechanism whereby it helps streptococci to evade phagocytosis has not been demonstrated. We investigated phagocytosis resistance in a strain of serotype M4 by inactivating the mrp gene and also the emm, enn, sof and sfbX genes and by analysing the effect on streptococcal growth in blood and on complement deposition on the bacterial surface. Inactivation of enn4 and sfbX4 had little impact on growth in blood, but ablation of mrp4, emm4 or sof4 reduced streptococcal growth in human blood, confirming that Mrp and Emm are required for optimal resistance to phagocytosis and providing the first indication that Sof may be an anti-phagocytic factor. Moreover, antisera against Mrp4, Emm4 and Sof4 promoted the killing of S. pyogenes, but anti-SfbX serum had no effect. Growth of S. pyogenes in blood was dependent on the presence of fibrinogen and in the absence of fibrinogen there was a twofold increase in complement deposition. Inactivation of mrp4 resulted in a loss of fibrinogen-binding and caused a twofold increase in the binding of C3b that was inhibited by Mg-EGTA. Mrp contained two fibrinogen-binding sites, one of which is within a highly conserved region. These findings indicate that Mrp-fibrinogen interactions prevent surface deposition of complement via the classical pathway, thereby contributing to the ability of these streptococci to resist phagocytosis. This may be a common mechanism for evasion of phagocytosis because Mrp is expressed by approximately half of the clinical isolates of S. pyogenes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16420362     DOI: 10.1111/j.1365-2958.2005.04977.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  40 in total

1.  Growth phase-dependent modulation of Rgg binding specificity in Streptococcus pyogenes.

Authors:  Srivishnupriya Anbalagan; Alexander Dmitriev; W Michael McShan; Paul M Dunman; Michael S Chaussee
Journal:  J Bacteriol       Date:  2012-05-25       Impact factor: 3.490

2.  Polymorphisms in Regulator of Cov Contribute to the Molecular Pathogenesis of Serotype M28 Group A Streptococcus.

Authors:  Paul E Bernard; Priyanka Kachroo; Jesus M Eraso; Luchang Zhu; Jessica E Madry; Sarah E Linson; Matthew Ojeda Saavedra; Concepcion Cantu; James M Musser; Randall J Olsen
Journal:  Am J Pathol       Date:  2019-07-29       Impact factor: 4.307

Review 3.  Tissue tropisms in group A streptococcal infections.

Authors:  Debra E Bessen; Sergio Lizano
Journal:  Future Microbiol       Date:  2010-04       Impact factor: 3.165

4.  Streptococcal protective antigens (Spa): a new family of type-specific proteins of group A streptococci.

Authors:  E A Ahmed; T A Penfound; S C Brewer; P A Tennant; E Y Chiang; J B Dale
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-10-29       Impact factor: 3.267

5.  Protective immunogenicity of group A streptococcal M-related proteins.

Authors:  James B Dale; Shannon E Niedermeyer; Tina Agbaosi; Nicholas D Hysmith; Thomas A Penfound; Claudia M Hohn; Matthew Pullen; Michael I Bright; Daniel S Murrell; Lori E Shenep; Harry S Courtney
Journal:  Clin Vaccine Immunol       Date:  2015-01-28

6.  Incremental Contributions of FbaA and Other Impetigo-Associated Surface Proteins to Fitness and Virulence of a Classical Group A Streptococcal Skin Strain.

Authors:  Candace N Rouchon; Anhphan T Ly; John P Noto; Feng Luo; Sergio Lizano; Debra E Bessen
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

7.  Structure-based design of broadly protective group a streptococcal M protein-based vaccines.

Authors:  James B Dale; Pierre R Smeesters; Harry S Courtney; Thomas A Penfound; Claudia M Hohn; Jeremy C Smith; Jerome Y Baudry
Journal:  Vaccine       Date:  2016-11-24       Impact factor: 3.641

Review 8.  The structure and function of serum opacity factor: a unique streptococcal virulence determinant that targets high-density lipoproteins.

Authors:  Harry S Courtney; Henry J Pownall
Journal:  J Biomed Biotechnol       Date:  2010-07-08

9.  Serum opacity factor is a streptococcal receptor for the extracellular matrix protein fibulin-1.

Authors:  Harry S Courtney; Yi Li; Waleed O Twal; W Scott Argraves
Journal:  J Biol Chem       Date:  2009-03-10       Impact factor: 5.157

10.  The small regulatory RNA FasX controls pilus expression and adherence in the human bacterial pathogen group A Streptococcus.

Authors:  Zhuyun Liu; Jeanette Treviño; Esmeralda Ramirez-Peña; Paul Sumby
Journal:  Mol Microbiol       Date:  2012-08-06       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.